W. Bauer, U. Briner, W. Doepfner, R. Haller, R. Huguenin, P. Marbach, T. J. Petcher, and J. Pless. SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci.
S. W. J. Lamberts, P. Uitterlinden, L. Verschoor, K. J. Van Dongen and E. Del Pozo. Long-term treatment of acromegaly with the somatostatin analogue SMS 201–995. N. Engl. J. Med.
S. M. Wood, M. E. Kraenzlin, T. E. Adrian, and S. R. Bloom. Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue. Symptomatic and peptide responses. Gut
G. Richter, F. Stockmann, B. Lemboke, J. M. Conlon, and W. Creutzfeldt. Short-term administration of the somatostatin analogue SMS 201–995 in patients with carcinoid tumours. Scand. J. Gastroenterol.
21(Suppl. 119):193–198, 1986.
K. Kutz, E. Nüesch, and J. Rosenthaler. Pharmacokinetics of SMS 201–995 in healthy subjects. Scand. J. Gastroenterol.
21(Suppl. 119):65–72, 1986.
E. Köhler, M. Duberow-Drewe, J. Drewe, G. Ribes, M. M. Loubatiéres-Mariani, N. Mazer, K. Gyr, and C. Beglinger. Absorption of an aqueous solution of a new synthetic somatostatin analogue administered to man by gavage. Eur. J. Clin. Pharmacol.
U. Theiβ, I. Kuhn, and P. W. Lücker. Iontophoresis—is there a future for clinical application? Meth. Find. Exp. Clin. Pharmacol. 13:353–359, 1991.
O. Siddiqui, Y. Sun, J.-C. Liu, and Y. W. Chien. Facilitated transdermal transport of insulin. J. Pharm. Sci. 76:341–345, 1987.
R. R. Burnette and D. Marero. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J. Pharm. Sci. 75:738–743, 1986.
J. E. Sanderson, R. W. Caldwell, J. Hsiao, R. Dixon, and R. R. Tuttle. Noninvasive delivery of a novel inotropic catecholamine: Iontophoretic vs. intravenous infusion in dogs. J. Pharm. Sci.
B. H. Sage. Technical and developmental issues of iontophoretic transport of peptide and protein drugs, in Trends and Future Perspectives in Peptide and Protein Delivery, edited by V. H. L. Lee, M. Hashida, and Y. Mizshima. Harwood Academic Publishers, Switzerland (in press).
M. Gibaldi and D. Perrier. Pharmacokinetics (2nd edition), Marcel Dekker, Inc., New York, 1982, pp. 445–449.
Z. Yu, J. B. Schwartz, E. T. Sugita, and H. C. Foehl. Five modified numerical deconvolution methods for biopharmaceutics and pharmacokinetics studies. Submitted for publication.
D. Vaughan and M. Dennis. Mathematical basis of point-area deconvolution method for determining in vivo input functions. J. Pharm. Sci.
IMSL. IMSL/IDL® Visual Numerics, Inc., Houston, TX, 1992.
G. Fricker, J. Drewe, J. Vonderscher, T. Kissel, and C. Beglinger. Enteral absorption of octreotide. Br. J. Pharmacol.
V. H. L. Lee. Peptide and protein drug delivery: opportunities and challenges. Pharm. Int.
G. E. Peters. Distribution and metabolism of exogenous somatostatin in rats. Regul. Peptides
M. Lemaire, M. Azria, R. Dannecker, P. Marbach, A. Schweitzer, and G. Mauer. Drug Metab. Dispos.
E. Del Pozo, M. Neufeld, K. Schlüter, F. Tortosa, P. Clarenbach, E. Bieder, L. Wendel, E. Nüesch, P. Marbach, H. Cramer, and L. Kerp. Endocrine profile of a long-acting somatostatin derivative SMS 201–995: Study in normal volunteers following subcutaneous administration. Acta Endocrinol.
A. J. Hoogstraate, V. Srinivasan, S. M. Sims, and W. I. Higuchi. Iontophoretic behavior of leuprolide versus model permeants. Proceed. Intern. Symp. Control. Rel. Bioact. Mater.,
B. Delgado-Charro and R. H. Guy. Transdermal delivery of nafarelin, an LHRH-analogue, by iontophoresis. Pharm. Res. 9(suppl):S-67, 1992.